These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Mitochondrial ischemia-reperfusion injury of the transplanted rat heart: improved protection by preservation versus cardioplegic solutions. Schneeberger S; Kuznetsov AV; Seiler R; Renz O; Meusburger H; Mark W; Brandacher G; Margreiter R; Gnaiger E Shock; 2008 Oct; 30(4):365-71. PubMed ID: 18317412 [TBL] [Abstract][Full Text] [Related]
9. Do preservation solutions protect rat cremaster microcirculation during ischemia and reperfusion? Bastiaanse J; Slaaf DW; oude Egbrink MG; Boeckx WD; Kon M J Surg Res; 2005 May; 125(2):182-8. PubMed ID: 15854672 [TBL] [Abstract][Full Text] [Related]
10. Direct assessment of the antioxidant effects of a new heart preservation solution, Celsior. A hemodynamic and electron spin resonance study. Pietri S; Culcasi M; Albat B; Albérici G; Menasché P Transplantation; 1994 Sep; 58(6):739-42. PubMed ID: 7940702 [No Abstract] [Full Text] [Related]
11. Poststorage diastolic abnormalities of heart transplants: is vascular dysfunction or myocardial contracture the culprit? Kevelaitis E; Mouas C; Menasché P J Heart Lung Transplant; 1996 May; 15(5):461-9. PubMed ID: 8771501 [TBL] [Abstract][Full Text] [Related]
12. Impact of acute ischemia-reperfusion on myocardial mitochondrial function in an ex-vivo model of global myocardial ischemia. Paiva MA; Carreira R; Monteiro P; Gonçalves LM; Providência LA Rev Port Cardiol; 2005 Nov; 24(11):1381-92. PubMed ID: 16463987 [TBL] [Abstract][Full Text] [Related]
13. Ischemic preconditioning with opening of mitochondrial adenosine triphosphate-sensitive potassium channels or Na/H exchange inhibition: which is the best protective strategy for heart transplants? Kevelaitis E; Oubénaissa A; Mouas C; Peynet J; Menasché P J Thorac Cardiovasc Surg; 2001 Jan; 121(1):155-62. PubMed ID: 11135172 [TBL] [Abstract][Full Text] [Related]
14. Advantages of Celsior solution in graft preservation from non-heart-beating donors in a canine liver transplantation model. Ohwada S; Sunose Y; Aiba M; Tsutsumi H; Iwazaki S; Totsuka O; Matsumoto K; Takeyoshi I; Morishita Y J Surg Res; 2002 Feb; 102(2):71-6. PubMed ID: 11796001 [TBL] [Abstract][Full Text] [Related]
15. A comparative study of cardiac preservation with Celsior or University of Wisconsin solution with or without prior administration of cardioplegia. Boku N; Tanoue Y; Kajihara N; Eto M; Masuda M; Morita S J Heart Lung Transplant; 2006 Feb; 25(2):219-25. PubMed ID: 16446224 [TBL] [Abstract][Full Text] [Related]
16. Celsior versus custodiol: early postischemic recovery after cardioplegia and ischemia at 5 degrees C. Ackemann J; Gross W; Mory M; Schaefer M; Gebhard MM Ann Thorac Surg; 2002 Aug; 74(2):522-9. PubMed ID: 12173839 [TBL] [Abstract][Full Text] [Related]
17. Cyclosporine A as a Cardioprotective Agent During Donor Heart Retrieval, Storage, or Transportation: Benefits and Limitations. Gao L; Hicks M; Villanueva JE; Doyle A; Chew HC; Qui MR; Jabbour A; Dhital KK; Macdonald PS Transplantation; 2019 Jun; 103(6):1140-1151. PubMed ID: 30801551 [TBL] [Abstract][Full Text] [Related]
18. Early reperfusion with warm, polarizing adenosine-lidocaine cardioplegia improves functional recovery after 6 hours of cold static storage. Rudd DM; Dobson GP J Thorac Cardiovasc Surg; 2011 Apr; 141(4):1044-55. PubMed ID: 20605028 [TBL] [Abstract][Full Text] [Related]
19. Comparative experimental study of myocardial protection with crystalloid solutions for heart transplantation. Lima ML; Fiorelli AI; Vassallo DV; Pinheiro BB; Stolf NA; Gomes OM Rev Bras Cir Cardiovasc; 2012; 27(1):110-6. PubMed ID: 22729308 [TBL] [Abstract][Full Text] [Related]
20. Improvement of rat lung structure and function after preservation with celsior. Fehrenbach A; Wittwer T; Cornelius J; Ochs M; Fehrenbach H; Wahlers T; Richter J J Surg Res; 1999 Apr; 82(2):285-93. PubMed ID: 10090841 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]